The US Food and Drug Administration (FDA) has granted 510(k) clearance to LivaNova’s Essenz heart-lung machine (HLM) for use in cardiopulmonary bypass (CPB) procedures.

This clearance will enable the company to begin the US commercial launch of the Essenz machine.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Essenz HLM has also recently been approved by Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

Following a successful limited commercial release, the company is also initiating a wider commercial launch of the system in Europe.

The company’s Essenz HLM and Essenz Patient Monitor feature the Essenz Perfusion System, which facilitates a patient-specific perfusion approach grounded in data-driven decisions.

Prior to the start of a CPB procedure, the HLM sensor checks confirm readiness.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Even though the Essenz HLM cockpit and Essenz Patient Monitor are connected, they operate independently.

Based on LivaNova S5 HLM, the Essenz Perfusion System can be adapted according to individual requirements, workflows and users.

The system uses advanced cable management and a mast-mounted design to lower distractions as well as keep the area clean and hygienic.

Its cockpit offers one central view for control of the device as well as checking all perfusion and patient parameters.

Furthermore, the system can be seamlessly incorporated with operating room (OR) external devices and hospital information systems.

Designed to support the perfusionist across a procedure, the Essenz Patient Monitor continuously records and displays data.

The technology platform can also accommodate a stream of future software features and functionalities, stated the company.

LivaNova CEO Damien McDonald said: “A perfusion system acts as a patient’s heart and lungs during an open-heart procedure, so having the highest-quality system backed by the expertise of a skilled perfusionist is paramount.

“When we were designing Essenz, perfusionists told us they needed a system that gives them access to comprehensive data to drive more informed decision-making throughout the entire procedure. We’ve done that with Essenz.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact